Filing Details
- Accession Number:
- 0001232524-14-000065
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-11 18:30:39
- Reporting Period:
- 2014-06-09
- Filing Date:
- 2014-06-11
- Accepted Time:
- 2014-06-11 18:30:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1232524 | Jazz Pharmaceuticals Plc | JAZZ | Pharmaceutical Preparations (2834) | 981032470 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1394522 | K Jeffrey Tobias | C/O Jazz Pharmaceuticals Plc Connaught House, 1 Burlington Rd, Fl. 4 Dublin 4 L2 | Evp, Research & Dev And Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2014-06-09 | 2,561 | $46.83 | 49,664 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2014-06-09 | 439 | $59.13 | 50,103 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2014-06-09 | 3,000 | $146.24 | 47,103 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Nonstatutory Stock Option (right to buy) | Disposition | 2014-06-09 | 2,561 | $0.00 | 2,561 | $46.83 |
| Ordinary Shares | Nonstatutory Stock Option (right to buy) | Disposition | 2014-06-09 | 439 | $0.00 | 439 | $59.13 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 32,580 | 2022-08-08 | No | 4 | M | Direct | |
| 19,559 | 2023-03-04 | No | 4 | M | Direct |
Footnotes
- The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Following the reported transaction, the remaining ordinary shares subject to this option will vest with respect to 23,048 shares in eighteen equal monthly installments from July 9, 2014 to December 9, 2015 and with respect to 9,532 shares in eight equal monthly installments from January 9, 2016 to August 9, 2016.
- Following the reported transaction, the remaining ordinary shares subject to this option are vested with respect to 3,934 shares and will vest with respect to 3,125 shares in six equal monthly installments from July 5, 2014 to December 5, 2014 and with respect to 12,500 shares in twenty-four equal monthly installments from January 5, 2015 to December 5, 2016.
Billionaire Hedge Funds
